Abnormal cervical cytology is associated with increased nitric oxide release in the uterine cervix

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 4, 2009, Pages 417-421

  Rahkola, Paivi ^a   Mikkola, Tomi S ^a   Nieminen, Pekka ^a   Ylikorkala, Olavi ^a   Vaisanen Tommiska, Mervi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

cervical cytology test; Human papillomavirus; nitric oxide

Indexed keywords

NITRIC OXIDE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FINLAND; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; METABOLITE; OUTCOME ASSESSMENT; PARITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SPONTANEOUS ABORTION; UTERINE CERVIX; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS; ADOLESCENT; BODY FLUID; CYTOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; POSTMENOPAUSE; SWEDEN; UTERINE CERVIX DYSPLASIA; VAGINA SMEAR; VIROLOGY;

ADOLESCENT; ADULT; BODY FLUIDS; CERVIX UTERI; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; NITRIC OXIDE; PAPILLOMAVIRUS INFECTIONS; POSTMENOPAUSE; SWEDEN; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS; YOUNG ADULT;

EID: 64849088742     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340902807181     Document Type: Article

References (26)

1. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:28-49.
2. Ekerhovd E, Brannstrom M, Weijdegard B, Norstrom A. Nitric oxide synthases in the human cervix at term pregnancy and effects of nitric oxide on cervical smooth muscle contractility. Am J Obstet Gynecol. 2000;183:610-6.
3. Vaisanen-Tommiska M, Mikkola TS, Ylikorkala O. Increased release of cervical nitric oxide in spontaneous abortion before clinical symptoms: a possible mechanism for preabortal cervical ripening. J Clin Endocrinol Metab. 2004;89:5622-6.
4. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;24:S1-15.
5. Purola E, Savia E. Cytology of gynecologic condyloma acuminatum. Acta Cytol. 1977;21:26-31.
6. Bollmann M, Bankfalvi A, Trosic A, Speich N, Schmittt C, Bollmann R. Can we detect cervical human papillomavirus (HPV) infection by cytomorphology alone? Diagnostic value of non-classic cytological signs of HPV effect in minimally abnormal pap tests. Cytopathology. 2005;16:13-21.
7. Bibbo M. Comprehensive cytopathology. Philadelphia, USA: W.B Saunders Company; 1991.
8. Koss L. Diagnostic cytology, 4th edn. Philadelphia, PA: J.B. Lippincott; 1992.
9. Tarkkanen J, Auvinen E, Nieminen P, Malmi R, Vartiainen J, Timonen, et al. HPV DNA testing as an adjunct in the management of patients with low grade cytological lesions in Finland. Acta Obstet Gynecol Scand. 2007;86:367-72.
10. Wright TC, Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ, et al. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2001;7:154-67.
11. Ridnour LA, Thomas DD, Donzelli S, Espey MG, Roberts DD, Wink DA, et al. The biphasic nature of nitric oxide responses in tumor biology. Antioxid Redox Signal. 2006;8: 1329-37.
12. Vaisanen-Tommiska M, Nuutila M, Aittomaki K, Hiilesmaa V, Ylikorkala O. Nitric oxide metabolites in cervical fluid during pregnancy: further evidence for the role of cervical nitric oxide in cervical ripening. Am J Obstet Gynecol. 2003;188: 779-85.
13. Smith JH. Bethesda 2001. Cytopathology. 2001;12:4-10.
14. Monsonego J, Bohbot JM, Pollini G, Krawec C, Vincent C, Merignargues I, et al. Performance of the roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear. Gynecol Oncol. 2005;99:160-8.
15. Yamamoto LS, Alves VA, Maeda MY, Longatto-Filho A, Utagawa ML, Eluf Neto J. A morphological protocol and guide-list on uterine cervix cytology associated to papillomavirus infection. Rev Inst Med Trop Sao Paulo. 2004;46: 189-93.
16. Cibas ES, Hong X, Crum CP, Feldman S. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep pap samples. Gynecol Oncol. 2007;104:702-6.
17. Nieminen P, Anttila A. Introducing HPV screening: challenges and fallacies. Acta Obstet Gynecol Scand. 2007;86: 1416-8.
18. De Andrea M, Mondini M, Azzimonti B, Dell'oste V, Germano S, Gaudino G, et al. Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression. Virus Res. 2007;124:220-5.
19. Hammes LS, Tekmal RR, Naud P, Edelweiss MI, Kirma N, Valente PT, et al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression - clinicopathological correlation. Gynecol Oncol. 2007;105: 157-65.
20. Akaike T, Maeda H. Nitric oxide and virus infection. Immunology. 2000;101:300-8.
21. Reiss CS, Komatsu T. Does nitric oxide play a critical role in viral infections? J Virol. 1998;72:4547-51.
22. Routes JM, Morris K, Ellison MC, Ryan S. Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms. J Virol. 2005;79:116-23.
23. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2001;2:149-56.
24. Goncalves TL, Erthal F, Corte CL, Muller LG, Piovezan CM, Nogueira CW, et al. Involvement of oxidative stress in the pre-malignant and malignant states of cervical cancer in women. Clin Biochem. 2005;38:1071-5.
25. Beevi SS, Rasheed MH, Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin Chim Acta. 2007;375:119-23.
26. Owens CL, Moats DR, Burroughs FH, Gustafson KS. "Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" is a distinct cytologic category: histologic outcomes and HPV prevalence. Am J Clin Pathol. 2007;128:398-403.